Genelux logo

Genelux Share Price Today

(NASDAQ: GNLX)

Genelux share price is $3.9 & ₹339.67 as on 5 Feb 2025, 2.30 'hrs' IST

$3.9

0.37

(10.48%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Genelux share price in Dollar and Rupees. Guide to invest in Genelux stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Genelux, along with analyst recommendations, forecasts, and comprehensive financials.

Genelux share price movements

  • Today's Low: $3.35
    Today's High: $3.96

    Day's Volatility :15.38%

  • 52 Weeks Low: $1.60
    52 Weeks High: $9.82

    52 Weeks Volatility :83.71%

Genelux (GNLX) Returns

PeriodGenelux CorpIndex (Russel 2000)
3 Months
29.14%
0.0%
6 Months
102.07%
0.0%
1 Year
-54.01%
0.0%
3 Years
-36.59%
-11.7%

Genelux (GNLX) Key Statistics

in dollars & INR

Previous Close
$3.53
Open
$3.43
Today's High
$3.96
Today's Low
$3.3508
Market Capitalization
$121.9M
Today's Volume
$151.9K
52 Week High
$9.82
52 Week Low
$1.6
Revenue TTM
$8.0K
EBITDA
$-27.0M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-88.57%

How to invest in Genelux Stock (GNLX) from India?

It is very easy for Indian residents to invest directly in Genelux from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Genelux stock in both Indian Rupees (INR) and US Dollars (USD). Search for Genelux or GNLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Genelux or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Genelux shares which would translate to 0.223 fractional shares of Genelux as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Genelux, in just a few clicks!

Returns in Genelux (GNLX) for Indian investors in Rupees

The Genelux stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Genelux investment value today

Current value as on today

₹50,894

Returns

₹49,106

(-49.11%)

Returns from Genelux Stock

₹54,009 (-54.01%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Genelux (GNLX)

173%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Genelux Stock from India on INDmoney has increased by 173% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Genelux

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Genelux(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Genelux Stock (GNLX)

What analysts predicted

Upside of 371.79%

Target:

$18.40

Current:

$3.90

Insights on Genelux Stock (Ticker Symbol: GNLX)

  • Price Movement

    In the last 1 month, GNLX stock has moved up by 53.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.46M → 8.0K (in $), with an average decrease of 99.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -7.85M → -6.46M (in $), with an average increase of 10.5% per quarter
  • GNLX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 113.3%

Genelux Technicals Summary

Sell

Neutral

Buy

Genelux is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Genelux (GNLX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Genelux Corp logo
53.54%
102.07%
-54.01%
-36.59%
-36.59%
Biontech Se logo
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Genelux Corp logo
NA
NA
NA
-0.89
-0.89
-0.45
NA
0.74
Biontech Se logo
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Genelux Corp logo
Buy
$121.9M
-36.59%
NA
0.0%
Biontech Se logo
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.4B
115.97%
NA
-15.86%

About Genelux

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
Organization
Genelux
Employees
24
CEO
Mr. Thomas Zindrick J.D.
Industry
Miscellaneous

Management People of Genelux

NameTitle
Mr. Thomas Zindrick J.D.
Chairman, CEO & President
Ms. Lourie S. Zak
Chief Financial Officer
Dr. Joseph Cappello Ph.D.
Chief Technical Officer
Mr. Sean Ryder J.D.
General Counsel & Corporate Secretary
Dr. Yong Yu Ph.D.
Senior Vice President of Clinical Development
Prof. Paul Scigalla M.D., Ph.D.
Chief Medical Officer
Mr. Ralph Smalling B.Sc.
VP & Head of Regulatory Affairs

Important FAQs about investing in GNLX Stock from India :

What is Genelux share price today?

Genelux share price today stands at $3.90, Open: $3.43 ; Previous Close: $3.53 ; High: $3.96 ; Low: $3.35 ; 52 Week High: $9.82 ; 52 Week Low: $1.60.

The stock opens at $3.43, after a previous close of $3.53. The stock reached a daily high of $3.96 and a low of $3.35, with a 52-week high of $9.82 and a 52-week low of $1.60.

Can Indians buy Genelux shares?

Yes, Indians can invest in the Genelux (GNLX) from India.

With INDmoney, you can buy Genelux at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Genelux at zero transaction cost.

How can I buy Genelux shares from India?

It is very easy to buy Genelux from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Genelux (GNLX) be purchased?

Yes, you can buy fractional shares of Genelux with INDmoney app.

What are the documents required to start investing in Genelux stocks?

To start investing in Genelux, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Genelux Stock (GNLX)?

Today’s highest price of Genelux (GNLX) is $3.96.

Today’s lowest price of Genelux (GNLX) is $3.35.

What is today's market capitalisation of Genelux?

Today's market capitalisation of Genelux GNLX is 121.9M

What is the 52 Week High and Low Range of Genelux Stock (GNLX)?

  • 52 Week High

    $9.82

  • 52 Week Low

    $1.60

What are the historical returns of Genelux (GNLX)?

  • 1 Month Returns

    53.54%

  • 3 Months Returns

    102.07%

  • 1 Year Returns

    -54.01%

  • 5 Years Returns

    -36.59%

Who is the Chief Executive Officer (CEO) of Genelux ?

Mr. Thomas Zindrick J.D. is the current Chief Executive Officer (CEO) of Genelux.